Intrexon reported $-7614000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US USD -41652000 3.32M
Amgen AMGN:US USD 2.66B 71M
Arrowhead Research ARWR:US USD -83830000 10.92M
AstraZeneca AZN:LN USD 2.26B 427M
Bluebird Bio BLUE:US USD -86480000 14.28M
Bristol Myers Squibb BMY:US USD 2.74B 461M
Gilead Sciences GILD:US USD 2.81B 784M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Immunogen IMGN:US USD -77429000 16.38M
Intrexon XON:US USD -7614000 15.91M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Mannkind MNKD:US USD -11409000 13.55M
Merk MRK:US USD 5.56B 156M
Novartis NOVN:VX USD 3.33B 8M
Peregrine Pharmaceuticals PPHM:US USD 2.74M 1.67M
Roche Holding ROG:VX 11.54B 2.84B
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Thermo Fisher Scientific TMO:US USD 1.74B 282M
Veracyte VCYT:US USD -9680000 2.25M
Xencor XNCR:US USD -38348000 10.35M
YTE INCY:US USD 118.25M 142.04M